Dow Jones

38,852.86

-0.55%

Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

Regístrate

Inicio
Invertir
Acciones
Estados Unidos
NASDAQ
App Pharmaceuticals (MM) (APPX)
App Pharmaceuticals (MM) (APPX) Noticias

APPX

App Pharmaceuticals (MM) (APPX)

App Pharmaceuticals (MM)

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:APPX

1 2 3 4 5 Próxima >

Fecha	Hora	Fuente	Título	Símbolo	Compañía
13/11/2018	12:13	GlobeNewswire Inc.	APPx Group Holdings, Inc. Signs LOI to Acquire Cimtel (Quebec) Inc.	NASDAQ:APPX	App Pharmaceuticals (MM)
06/11/2018	08:49	GlobeNewswire Inc.	APPx Group Holdings, Inc. Trading on CSE Under Symbol “APPX”	NASDAQ:APPX	App Pharmaceuticals (MM)
10/09/2008	10:17	Edgar (US Regulatory)	App Pharmaceuticals, Inc.-Filing of certain prospectuses and communications for business combination transactions (425)	NASDAQ:APPX	App Pharmaceuticals (MM)
05/09/2008	11:56	Edgar (US Regulatory)	App Pharmaceuticals, Inc. - Current report filing (8-K)	NASDAQ:APPX	App Pharmaceuticals (MM)
03/09/2008	15:05	PR Newswire (US)	Mergent, Inc. Announces Changes to the HealthShares(TM) Cancer Index, Composite Index, Dermatology and Wound Care Index, Enablin	NASDAQ:APPX	App Pharmaceuticals (MM)
21/08/2008	05:01	Edgar (US Regulatory)	App Pharmaceuticals, Inc. - Information Statement - Merger or Acquisition (definitive) (DEFM14C)	NASDAQ:APPX	App Pharmaceuticals (MM)
18/08/2008	15:59	Business Wire	APP Pharmaceuticals Receives Manufacturing Approval for Three Product Codes of Heparin at Puerto Rico Facility	NASDAQ:APPX	App Pharmaceuticals (MM)
18/08/2008	05:02	Edgar (US Regulatory)	App Pharmaceuticals, Inc. - Information Statements (revised) (PRER14C)	NASDAQ:APPX	App Pharmaceuticals (MM)
04/08/2008	15:28	Edgar (US Regulatory)	App Pharmaceuticals, Inc. - Quarterly Report (10-Q)	NASDAQ:APPX	App Pharmaceuticals (MM)
01/08/2008	05:15	Edgar (US Regulatory)	App Pharmaceuticals, Inc. - Information Statement - Merger or Acquisition (preliminary) (PREM14C)	NASDAQ:APPX	App Pharmaceuticals (MM)
31/07/2008	19:13	Business Wire	APP Pharmaceuticals Reports 2008 Second Quarter Net Revenues of $198 Million, Operating Income of $53 Million	NASDAQ:APPX	App Pharmaceuticals (MM)
24/07/2008	15:35	Business Wire	APP Pharmaceuticals Announces Date for 2008 Second Quarter Financial Results and Investor Conference Call	NASDAQ:APPX	App Pharmaceuticals (MM)
10/07/2008	11:01	Edgar (US Regulatory)	App Pharmaceuticals, Inc. - Amended Statement of Beneficial Ownership (SC 13D/A)	NASDAQ:APPX	App Pharmaceuticals (MM)
08/07/2008	07:30	Marketwired	Market Pulse Breaking News Alert for Tuesday, July 8, 2008: PRRY -- Planet Resource Recovery Receives Significant Purchase Order	NASDAQ:APPX	App Pharmaceuticals (MM)
03/07/2008	07:00	Business Wire	APP Pharmaceuticals Receives Final Approvals for Additional Dosages of Granisetron Hydrochloride Injection, USP	NASDAQ:APPX	App Pharmaceuticals (MM)
30/06/2008	15:53	Edgar (US Regulatory)	App Pharmaceuticals, Inc. - Annual Report of Employee Stock Plans (11-K)	NASDAQ:APPX	App Pharmaceuticals (MM)
02/06/2008	09:59	Business Wire	APP Pharmaceuticals Launches Enhanced Labeling for Heparin Sodium Injection, USP	NASDAQ:APPX	App Pharmaceuticals (MM)
15/05/2008	05:55	Business Wire	APP Pharmaceuticals Provides Update on Issues Related to Heparin Crisis and Actions to Ensure Uninterrupted Safe Supply	NASDAQ:APPX	App Pharmaceuticals (MM)
08/05/2008	15:08	Edgar (US Regulatory)	App Pharmaceuticals, Inc. - Initial Statement of Beneficial Ownership (3)	NASDAQ:APPX	App Pharmaceuticals (MM)
08/05/2008	07:05	Business Wire	APP Pharmaceuticals Reports 2008 First Quarter Net Revenues of $148 Million, Gross Profit of $70 Million	NASDAQ:APPX	App Pharmaceuticals (MM)
01/05/2008	07:00	Business Wire	APP Pharmaceuticals Announces Date for 2008 First Quarter Financial Results and Investor Conference Call	NASDAQ:APPX	App Pharmaceuticals (MM)
30/04/2008	19:16	Business Wire	APP Pharmaceuticals Names Thomas H. Silberg Chief Executive Officer; Appoints Richard J. Tajak Chief Financial Officer	NASDAQ:APPX	App Pharmaceuticals (MM)
29/04/2008	16:32	Edgar (US Regulatory)	App Pharmaceuticals, Inc. - Amended Annual Report (10-K/A)	NASDAQ:APPX	App Pharmaceuticals (MM)
21/04/2008	07:00	Business Wire	APP Pharmaceuticals Receives FDA Approval for Colistimethate For Injection, USP	NASDAQ:APPX	App Pharmaceuticals (MM)
25/03/2008	07:00	Business Wire	APP Pharmaceuticals Launches Cefepime Hydrochloride for Injection	NASDAQ:APPX	App Pharmaceuticals (MM)
17/03/2008	16:30	Edgar (US Regulatory)	App Pharmaceuticals, Inc. - Annual Report (10-K)	NASDAQ:APPX	App Pharmaceuticals (MM)
14/03/2008	15:39	Edgar (US Regulatory)	App Pharmaceuticals, Inc. - Statement of Ownership (SC 13G)	NASDAQ:APPX	App Pharmaceuticals (MM)
07/03/2008	07:05	Business Wire	APP Pharmaceuticals Reports Record Net Revenues of $647 Million and Gross Profit of $315 Million from Continuing Operations in 2	NASDAQ:APPX	App Pharmaceuticals (MM)
28/02/2008	15:30	Business Wire	APP Pharmaceuticals Announces Date for Fourth Quarter and Full-Year Financial Results and Investor Conference Call	NASDAQ:APPX	App Pharmaceuticals (MM)
28/02/2008	15:17	Edgar (US Regulatory)	App Pharmaceuticals, Inc. - Notification that Annual Report will be submitted late (NT 10-K)	NASDAQ:APPX	App Pharmaceuticals (MM)